PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
Clinical trial NCT01074970 · COMPLETED
Trial details
- NCT number
- NCT01074970
- Sponsor
- Hoosier Cancer Research Network
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2018-12-15
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.